Logo image
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
Journal article   Open access   Peer reviewed

P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro

Helena S.Y. Mancebo, Gary Lee, John Flygare, Joanne Tomassini, Percy Luu, Yuerong Zhu, Junmin Peng, Carol Blau, Daria Hazuda, David Price, …
Genes & development, Vol.11(20), pp.2633-2644
10/15/1997
DOI: 10.1101/gad.11.20.2633
PMCID: PMC316604
PMID: 9334326
url
https://doi.org/10.1101/gad.11.20.2633View
Published (Version of record) Open Access

Abstract

To identify novel inhibitors of transcriptional activation by the HIV Tat protein, we used a combination of in vitro and in vivo Tat-dependent transcription assays to screen >100,000 compounds. All compounds identified blocked Tat-dependent stimulation of transcriptional elongation. Analysis of a panel of structurally diverse inhibitors indicated that their target is the human homolog of Drosophila positive transcription elongation factor b (P-TEFb). Loss of Tat transactivation in extracts depleted of the kinase subunit of human P-TEFb, PITALRE, was reversed by addition of partially purified human P-TEFb. Transfection experiments with wild-type or kinase knockout PITALRE demonstrated that P-TEFb is required for Tat function. Our results suggest that P-TEFb represents an attractive target for the development of novel HIV therapeutics.
HIV Tat protein kinase inhibitors P-TEFb kinase Research Paper transcriptional activation

Details

Metrics

106 readers on Mendeley
2 readers on CiteULike
Logo image